Analysis of AT1-B2 receptor heterodimerization in transgenic mice

Experimental and Clinical Cardiology

Volumn 20, Issue 1, 2014, Pages 1626-1634

  Quitterer, Ursula ^a,b   AbdAlla, Said ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Angiotensin II AT1 receptor; Bradykinin B2 receptor; FRET; Heterodimerization; Transgenic mice

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; BRADYKININ B2 RECEPTOR;

ANIMAL EXPERIMENT; AORTA MEDIA; ARTICLE; BINDING SITE; CONTROLLED STUDY; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENOTYPE; HISTOLOGY; IMMUNOHISTOLOGY; MOUSE; NONHUMAN; PRESSOR RESPONSE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE FIBER;

EID: 84897116156     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mentz RJ, Bakris GL, Waeber B, McMurray JJ, Gheorghiade M, Ruilope LM, et al. The past, present and future of renin-angiotensin aldosterone system. Int J Cardiol 2013;167:1677-1687.
2. Peach MJ. Renin-angiotensin system: biochemistry and mechanism of action. Physiol Rev 1977;57:313- 370. (Pubitemid 8097628)
3. Basso N, Terragno NA. History about the discovery of the renin-angiotensin system. Hypertension 2001;38:1246-1249. (Pubitemid 34033396)
4. von Lueder TG, Krum H. RAAS inhibitors and cardiovascular protection in large scale trials. Cardiovasc Drugs Ther 2013;27:171-179.
5. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-251. (Pubitemid 23191415)
6. Frey EK, Kraut H. Ein neues Kreislaufhormon und seine Wirkung. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 1928;133:1-56.
7. Rocha e Silva M, Beraldo WT, Rosenfeld G. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Am J Physiol 1949; 156:261-273.
8. Regoli D, Barabé J, Park WK. Receptors for bradykinin in rabbit aortae. Can J Physiol Pharmacol 1977;55:855-867. (Pubitemid 8154215)
9. McEachern AE, Shelton ER, Bhakta S, Obernolte R, Bach C, Zuppan P, et al. Expression cloning of a rat B2 bradykinin receptor. Proc. Natl. Acad Sci USA 1991;88:7724-7728. (Pubitemid 21915227)
10. Takagaki Y, Kitamura N, Nakanishi S. Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight prekininogens. Primary structures of two human prekininogens. J Biol Chem 1985;260:8601-8609. (Pubitemid 15011836)
11. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995;47:25-49.
12. Alhenc-Gelas F, Bouby N, Richer C, Potier L, Roussel R, Marre M. Kinins as therapeutic agents in cardiovascular and renal diseases. Curr Pharm Des 2011;17:2654-2662.
13. Regoli D, Plante GE, Gobeil F Jr. Impact of kinins in the treatment of cardiovascular diseases. Pharmacol Ther 2012;135:94-111.
14. Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 1998;339:1285-1292. (Pubitemid 28496194)
15. AbdAlla S, Lother H, Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 2000;407:94-98.
16. AbdAlla S, Lother H, el Massiery A, Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001;7:1003-1009. (Pubitemid 32937379)
17. Hansen JL, Hansen JT, Speerschneider T, Lyngso C, Erikstrup N, Burstein ES, et al. Lack of evidence for AT1R/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R/B2R heterodimer? J Biol Chem 2009;284:1831-1839.
18. See HB, Seeber RM, Kocan M, Eidne KA, Pfleger KD. Application of G protein-coupled receptorheteromer identification technology to monitor barrestin recruitment to G protein-coupled receptor heteromers. Assay Drug Dev Technol 2011;9:21-30.
19. Quitterer U, Pohl A, Langer A, Koller S, Abdalla S. A cleavable signal peptide enhances cell surface delivery and heterodimerization of Ceruleantagged angiotensin II AT1 and bradykinin B2 receptor. Biochem Biophys Res Commun 2011; 409:544-549.
20. Wilson PC, Lee MH, Appleton KM, El-Shewy HM, Morinelli TA, Peterson YK, et al. The arrestinselective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signalling via AT1-B2 receptor heterodimers. J Biol Chem 2013;288:18872- 18884.
21. Borkowski JA, Ransom RW, Seabrook Gr, Trumbauer M, Chen H, Hill RG, et al. Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J Biol Chem 1995;270:13706- 13710.
22. Fu X, Koller S, Abd Alla J, Quitterer U. Inhibition of G-protein-coupled receptor kinase 2 (GRK2) triggers the growth-promoting mitogen-activated protein kinase (MAPK) pathway. J Biol Chem 2013;288:7738-7755.
23. Abdalla S, Fu X, Elzahwy SS, Klaetschke K, Streichert T, Quitterer U. Up-regulation of the cardiac lipid metabolism at the onset of heart failure. Cardiovasc Hematol Agents Med Chem 2011;9:190-206.
24. Abd Alla J, Langer A, Elzahwy SS, Arman-Kalcek G, Streichert T, Quitterer U. Angiotensin-converting enzyme inhibition down-regulates the proatherogenic chemokine receptor 9 (CCR9)- chemokine ligand 25 (CCL25) axis. J Biol Chem 2010;285:23496-23505.
25. Rong JX, Shapiro M, Trogan E, Fisher EA. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci USA 2003;100:13531- 13536. (Pubitemid 37444776)
26. AbdAlla S, Lother H, Langer A, el Faramawy Y, Quitterer U. Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis. Cell 2004;119:343-354. (Pubitemid 39423837)
27. Okorokov, AL, Rubbi, CP, Metcalfe S, Milner J. The interaction of p53 with the nuclear matrix is mediated by F-actin and modulated by DNA damage. Oncogene 2002;21:356-367. (Pubitemid 34123798)
28. Batard P, Szollosi J, Luescher I, Cerottini JC, MacDonald R, Romero P. Use of phycoerythrin and allophycocyanin for fluorescence resonance energy transfer analyzed by flow cytometry: advantages and limitations. Cytometry 2002;48:97-105. (Pubitemid 34591922)
29. Quitterer U, Lother H, Abdalla S. AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia. Semin Nephrol 2004;24:115-119. (Pubitemid 38387852)
30. Alfie ME, Yang XP, Hess F, Carretero OA. Saltsensitive hypertension in bradykinin B2 receptor knockout mice. Biochem Biophys Res Commun 1996;224:625-630. (Pubitemid 26278638)
31. Alfie ME, Sigmon DH, Pomposiello SI, Carretero OA. Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors. Hypertension 1997;29:483-487. (Pubitemid 27074087)
32. Leonard AM, Chafe LL, Montani JP, van Vliet BN. Increased salt-sensitivity in endothelial nitric oxide synthase-knockout mice. Am J Hypertens 2006;19:1264-1269. (Pubitemid 44856255)
33. Kopkan L, Hess A, Huskova Z, Cervenka L, Navar LG, Majid DS. High-salt intake enhances superoxide activity in eNOS knockout mice leading to the development of salt sensitivity. Am J Physiol Renal Physiol 2010;299:F656-F663.
34. AbdAlla S, Abdel-Baset A, Lother H, el Massiery A, Quitterer U. Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension. J Mol Neurosci 2005;26:185-192. (Pubitemid 41389411)
35. Shen B, Harrison-Bernhard LM, Fuller AJ, Vanderpool V, Saifudeen Z, El-Dahr SS. The bradykinin B2 receptor gene is a target of angiotensin II type 1 receptor signalling. J Am Soc Nephrol 2007;18:1140-1149. (Pubitemid 46536900)